Cleveland BioLabs (CBLI)
Cleveland BioLabs Tangible Book Value Per Share: 0.4898
View CBLI Tangible Book Value Per Share with YCharts Pro.
Access these YCharts Pro features:
Export any data you want
Save any chart as an image
Utilize advanced screener power
View 30 years of financial history
over 90 advanced calculations
Enjoy an advertising free experience
CBLI Tangible Book Value Per Share Rankings
| Overall | 81st percentile | 806 of 4377 |
| Sector | 66th percentile | 166 of 503 in Healthcare |
| Industry | 62nd percentile | 60 of 158 in Biotechnology |
CBLI Tangible Book Value Per Share Range, Past 5 Years
| Minimum | -1.245 | Sep 2008 |
| Maximum | 0.6329 | Jun 2011 |
| Average | -0.2793 |
About Tangible Book Value Per Share
Tangible Book Value Per Share is the portion of tangible assets on a company's balance sheet attributable to each share of common stock.
Tangible book value excludes:
- Goodwill
- Items classified as "Intangible Assets" on the balance sheet
Learn More
You may also be interested in these CBLI related companies
CBLI News
$CBLI filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/3aaL
about 27 days ago by MarketBrief
about 27 days ago by MarketBrief
Cleveland BioLabs and Incuron Announce Russian Regulatory Allowance of IND for Phase 1B Trial of CBLC137
Apr 30, 9:00AM GlobeNewswire
Apr 30, 9:00AM GlobeNewswire
Cleveland BioLabs to Report First Quarter Financial Results and Provide Operational Update on May 3
Apr 25, 9:00AM GlobeNewswire
Apr 25, 9:00AM GlobeNewswire
Cleveland BioLabs Provides Update on BARDA Development Funding Process and Meetings With FDA
Apr 03, 6:03PM GlobeNewswire
Apr 03, 6:03PM GlobeNewswire
Cleveland BioLabs (CBLI) Shares Volatile Following New Outperform Rating at Rodman & Renshaw
Mar 14, 3:56PM Street Insider
Mar 14, 3:56PM Street Insider
RT @danshep55 New positions bought friday $NOAH 8 $GMXR 1/2 left 1.97 $CBLI 3.40/thx for the update - good to know what the pros are doing
about 92 days ago by ivan_bg
about 92 days ago by ivan_bg
Cleveland BioLabs Announces Science Publication on Molecular Mechanisms Underlying CBLB502's Interaction With TLR5
Feb 16, 2:00PM GlobeNewswire
Feb 16, 2:00PM GlobeNewswire
Cleveland BioLabs to Present at 14th Annual BIO CEO and Investor Conference
Feb 06, 9:00AM Marketwire
Feb 06, 9:00AM Marketwire
Cleveland Biolabs (CBLI) Fonstein to Step Down as CEO, Will Remain Pres; Kogan Named Interim CEO
Jan 24, 9:07AM Street Insider
Jan 24, 9:07AM Street Insider
Cleveland BioLabs Publishes Manuscript on New Radiation Countermeasure CBLB613
Jan 17, 9:00AM Marketwire
Jan 17, 9:00AM Marketwire
Cleveland BioLabs to Present at Noble Financial Eighth Annual Equity Conference
Jan 11, 9:00AM Marketwire
Jan 11, 9:00AM Marketwire
$CBLI moving on the back of $DNDN SQUEEZE ...to funny...next $CLDX to $5.00 a possibility
about 144 days ago by EXPstocktrader
about 144 days ago by EXPstocktrader
$CBLI http://stks.co/1m7z Updated chart. Alerted at $2.99. Screw you @traderdigs
about 144 days ago by VexTrades
about 144 days ago by VexTrades
Cleveland BioLabs Announces Opening of New IND for CBLB502 in Cancer Patients
Oct 19, 9:02AM Benzinga
Oct 19, 9:02AM Benzinga
Journal of Immunology Publishes Study of Cleveland BioLabs' Drug CBLB502 in Acute Renal Ischemic Failure
Oct 03, 9:00AM Marketwire
Oct 03, 9:00AM Marketwire
Cleveland BioLabs (CBLI) Enters Joint Stock Agreement with RUSNANO for Panacela Labs Funding
Sep 26, 8:02AM Street Insider
Sep 26, 8:02AM Street Insider
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| CBLI | 1.30 | +0.09 | +7.44% | 46.29M |
| CBL | 17.54 | -0.02 | -0.11% | 2.606B |
| CBKN | 2.16 | -0.04 | -1.82% | 185.33M |
| CBK | 1.32 | -0.06 | -4.35% | 47.52M |
| CBIN | 13.13 | +0.19 | +1.47% | 43.59M |
| CBI | 37.12 | -0.53 | -1.41% | 3.628B |
| CEA | 14.45 | -0.10 | -0.69% | 2.769B |
| CE | 40.78 | -0.03 | -0.07% | 6.395B |
| CDZI | 7.89 | -0.21 | -2.59% | 121.82M |
| CDY | 0.7099 | -0.00 | -0.01% | 65.15M |
